658 results on '"Buzdin Anton"'
Search Results
152. The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination
153. Genome-wide comparison of differences in the integration sites of interspersed repeats between closely related genomes
154. Exploration of the Transcriptional Landscape of ALPPS Reveals the Pathways of Accelerated Liver Regeneration
155. H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks
156. Correction: Nikitin, D., et al. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution. Cells 2019, 8, 130
157. High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
158. New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets
159. RNA sequencing analysis for profiling activation of cancer-associated molecular pathways.
160. RNA-sequencing and bioinformatic analysis to pre-assess sensitivity to targeted therapeutics in recurrent glioblastoma.
161. Oncobox, gene expression-based second opinion system for predicting response to treatment in advanced solid tumors.
162. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution
163. Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
164. FLOating-Window Projective Separator (FloWPS): A Data Trimming Tool for Support Vector Machines (SVM) to Improve Robustness of the Classifier
165. Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
166. High-Throughput Mutation Data Now Complement Transcriptomic Profiling: Advances in Molecular Pathway Activation Analysis Approach in Cancer Biology
167. Anticancer Activity of the Goat Antimicrobial Peptide ChMAP-28
168. Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs
169. Activation of STING in T cells induces type I IFN responses and cell death
170. The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat
171. RNA sequencing for research and diagnostics in clinical oncology.
172. Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
173. Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III
174. Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data
175. Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis
176. Correction: The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat
177. Hair growth stimulation by a Natural Remedy: Animal Studies
178. Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins
179. A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency
180. Functional Properties of Circulating Exosomes Mediated by Surface-Attached Plasma Proteins
181. Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation
182. The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat
183. Individual Drug Treatment Prediction in Oncology Based on Machine Learning Using Cell Culture Gene Expression Data
184. Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data
185. Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
186. Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
187. Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
188. Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA
189. Activation of intracellular signaling pathways as a new type of biomarkers for selection of target anticancer drugs.
190. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
191. Perspectives and Challenges in Molecular-Based Diagnostics and Personalized Treatment for Recurrent High-Grade Gliomas
192. VEGF blockade enhances the antitumor effect ofBRAF V600E inhibition
193. Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells
194. Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
195. In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
196. Early stage of cytomegalovirus infection suppresses host microRNA expression regulation in human fibroblasts
197. In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
198. Data Aggregation at the Level of Molecular Pathways Improves Stability of Experimental Transcriptomic and Proteomic Data
199. Common pathway signature in lung and liver fibrosis
200. MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.